secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silo Pharma, Inc. (SILO)
CIK:        0001514183
Form:       8-K
Filed at:   2026-07-10T22:29:27+00:00
Accession:  0001213900-26-077296
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Silo Pharma raises $4M in private placement; warrants could add $7.7M
---------------------------------------------------------------------

- Issued 619,965 shares (or pre-funded warrants) at $6.452/share plus Series A-3 and A-4 warrants.
- Warrants exercisable at $6.21/share; Series A-3 expire 5 years, Series A-4 expire 18 months after registration.
- Net proceeds expected ~$3.5M after fees; H.C. Wainwright acted as placement agent.
- Proceeds to be used for working capital and general corporate purposes.
- Potential additional $7.7M if all warrants exercised for cash; no assurance of exercise.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1514183/000121390026077296/0001213900-26-077296-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1514183/000121390026077296/ea0297602-8k_silo.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-077296

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer